Pharma Total Assets vs Net Debt Analysis

0RC6 Stock   75.72  2.97  4.08%   
Pharma Mar financial indicator trend analysis is much more than just breaking down Pharma Mar SAU prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pharma Mar SAU is a good investment. Please check the relationship between Pharma Mar Total Assets and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Pharma Mar SAU. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Assets vs Net Debt

Total Assets vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pharma Mar SAU Total Assets account and Net Debt. At this time, the significance of the direction appears to have pay attention.
The correlation between Pharma Mar's Total Assets and Net Debt is -0.84. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Net Debt in the same time period over historical financial statements of Pharma Mar SAU, assuming nothing else is changed. The correlation between historical values of Pharma Mar's Total Assets and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Pharma Mar SAU are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Total Assets i.e., Pharma Mar's Total Assets and Net Debt go up and down completely randomly.

Correlation Coefficient

-0.84
Relationship DirectionNegative 
Relationship StrengthSignificant

Total Assets

Total assets refers to the total amount of Pharma Mar assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Pharma Mar SAU books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from Pharma Mar's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pharma Mar SAU current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Pharma Mar SAU. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Pharma Mar's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 10.1 M in 2024, despite the fact that Discontinued Operations is likely to grow to (1.9 M).
 2021 2022 2023 2024 (projected)
Gross Profit213.4M182.7M148.5M114.0M
Total Revenue229.8M196.3M158.2M146.3M

Pharma Mar fundamental ratios Correlations

-0.750.810.620.890.35-0.840.680.060.820.160.490.930.08-0.220.340.120.87-0.370.490.99-0.66-0.650.170.570.72
-0.75-0.67-0.11-0.79-0.470.91-0.740.04-0.81-0.1-0.25-0.8-0.370.480.050.17-0.870.520.0-0.760.880.74-0.03-0.68-0.59
0.81-0.670.60.75-0.03-0.690.82-0.070.57-0.160.380.85-0.250.20.430.160.71-0.650.550.82-0.75-0.680.480.380.83
0.62-0.110.60.34-0.1-0.180.240.10.210.180.40.43-0.510.20.540.570.28-0.120.790.61-0.11-0.110.45-0.090.59
0.89-0.790.750.340.46-0.870.730.090.790.110.140.90.25-0.15-0.020.130.88-0.370.120.86-0.67-0.730.250.70.45
0.35-0.47-0.03-0.10.46-0.470.150.360.50.37-0.30.30.78-0.78-0.480.070.440.09-0.390.31-0.27-0.36-0.120.68-0.16
-0.840.91-0.69-0.18-0.87-0.47-0.70.02-0.96-0.11-0.28-0.9-0.450.41-0.080.24-0.930.4-0.13-0.830.770.840.1-0.75-0.56
0.68-0.740.820.240.730.15-0.70.210.55-0.120.220.74-0.020.030.160.030.75-0.910.210.68-0.91-0.670.350.460.63
0.060.04-0.070.10.090.360.020.21-0.020.36-0.21-0.070.21-0.13-0.10.30.01-0.22-0.040.0-0.180.26-0.020.11-0.13
0.82-0.810.570.210.790.5-0.960.55-0.020.210.340.840.5-0.510.15-0.280.9-0.260.190.81-0.65-0.77-0.270.690.5
0.16-0.1-0.160.180.110.37-0.11-0.120.360.21-0.11-0.10.24-0.43-0.280.330.10.23-0.130.040.030.3-0.33-0.08-0.2
0.49-0.250.380.40.14-0.3-0.280.22-0.210.34-0.110.46-0.21-0.050.82-0.350.27-0.210.750.54-0.28-0.11-0.230.110.76
0.93-0.80.850.430.90.3-0.90.74-0.070.84-0.10.460.18-0.150.35-0.090.87-0.450.420.94-0.72-0.830.170.730.74
0.08-0.37-0.25-0.510.250.78-0.45-0.020.210.50.24-0.210.18-0.73-0.38-0.470.270.19-0.480.05-0.17-0.31-0.580.72-0.25
-0.220.480.20.2-0.15-0.780.410.03-0.13-0.51-0.43-0.05-0.15-0.730.290.26-0.37-0.150.29-0.220.240.20.52-0.440.04
0.340.050.430.54-0.02-0.48-0.080.16-0.10.15-0.280.820.35-0.380.29-0.220.05-0.230.940.39-0.13-0.09-0.06-0.030.72
0.120.170.160.570.130.070.240.030.3-0.280.33-0.35-0.09-0.470.26-0.22-0.090.040.060.070.140.250.71-0.3-0.13
0.87-0.870.710.280.880.44-0.930.750.010.90.10.270.870.27-0.370.05-0.09-0.470.140.87-0.76-0.80.040.60.54
-0.370.52-0.65-0.12-0.370.090.4-0.91-0.22-0.260.23-0.21-0.450.19-0.15-0.230.04-0.47-0.21-0.40.820.45-0.33-0.19-0.57
0.490.00.550.790.12-0.39-0.130.21-0.040.19-0.130.750.42-0.480.290.940.060.14-0.210.52-0.14-0.10.13-0.060.76
0.99-0.760.820.610.860.31-0.830.680.00.810.040.540.940.05-0.220.390.070.87-0.40.52-0.67-0.690.190.580.76
-0.660.88-0.75-0.11-0.67-0.270.77-0.91-0.18-0.650.03-0.28-0.72-0.170.24-0.130.14-0.760.82-0.14-0.670.65-0.14-0.53-0.66
-0.650.74-0.68-0.11-0.73-0.360.84-0.670.26-0.770.3-0.11-0.83-0.310.2-0.090.25-0.80.45-0.1-0.690.65-0.15-0.68-0.49
0.17-0.030.480.450.25-0.120.10.35-0.02-0.27-0.33-0.230.17-0.580.52-0.060.710.04-0.330.130.19-0.14-0.15-0.090.19
0.57-0.680.38-0.090.70.68-0.750.460.110.69-0.080.110.730.72-0.44-0.03-0.30.6-0.19-0.060.58-0.53-0.68-0.090.31
0.72-0.590.830.590.45-0.16-0.560.63-0.130.5-0.20.760.74-0.250.040.72-0.130.54-0.570.760.76-0.66-0.490.190.31
Click cells to compare fundamentals

Pharma Mar Account Relationship Matchups

Pharma Mar fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets124.7M330.3M368.4M393.3M341.2M276.5M
Short Long Term Debt Total86.1M56.7M49.3M42.6M43.7M82.0M
Other Current Liab12.6M57.1M45.4M55.1M51.9M54.5M
Total Current Liabilities60.4M94.9M86.3M97.3M95.9M81.0M
Total Stockholder Equity11.4M102.7M177.9M223.0M193.4M203.1M
Property Plant And Equipment Net25.8M25.5M30.6M34.7M47.6M26.1M
Net Debt68.5M(39.5M)(64.0M)(107.2M)(16.4M)(15.5M)
Retained Earnings(69.6M)41.9M121.3M156.5M142.2M149.3M
Accounts Payable16.5M21.0M26.9M27.5M29.2M28.4M
Cash17.6M96.2M113.3M149.8M60.0M53.4M
Non Current Assets Total74.7M84.6M73.2M118.1M88.6M73.5M
Non Currrent Assets Other4.8M100.2M89.4M33.5M1.4M1.3M
Cash And Short Term Investments20.9M195.5M201.9M182.4M162.6M170.7M
Common Stock Shares Outstanding18.4M18.3M18.1M18.1M17.9M19.8M
Liabilities And Stockholders Equity124.7M330.3M368.4M393.3M341.2M276.5M
Non Current Liabilities Total56.8M132.6M104.1M73.0M51.9M78.1M
Inventory8.9M11.9M10.5M27.7M39.3M22.5M
Other Current Assets8.6M14.1M31.9M35.7M23.2M15.6M
Other Stockholder Equity69.8M49.8M45.6M55.4M40.2M38.2M
Total Liab117.2M227.5M190.5M170.3M147.8M159.1M
Total Current Assets50.0M245.7M295.2M275.2M252.6M175.4M
Short Term Debt31.3M16.8M14.0M14.7M14.8M24.0M
Intangible Assets6.1M3.9M3.2M2.6M1.9M1.8M
Short Term Investments3.3M99.3M88.5M32.6M102.5M107.7M
Current Deferred Revenue10.1M52.2M39.6M26.1M25.9M19.8M
Net Receivables13.2M26.7M78.9M29.3M47.8M44.4M
Other Assets47.2M37.9M33.7M30.6M35.1M40.5M
Accumulated Other Comprehensive Income12K15K14K38K19K14.3K
Other Liab2.0M92.7M68.8M45.1M51.8M40.3M
Net Tangible Assets10.5M101.7M176.8M221.8M255.0M267.8M
Deferred Long Term Liab5.2M2.8M2.1M1.4M1.3M1.2M
Property Plant Equipment25.6M24.7M26.9M36.9M42.5M31.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pharma Stock Analysis

When running Pharma Mar's price analysis, check to measure Pharma Mar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Mar is operating at the current time. Most of Pharma Mar's value examination focuses on studying past and present price action to predict the probability of Pharma Mar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Mar's price. Additionally, you may evaluate how the addition of Pharma Mar to your portfolios can decrease your overall portfolio volatility.